Methenamine

Methenamine

SCHEMBL5033140

C1N2CN3CN1CN(C2)C3.Cl.[Ni]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Methenamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methenamine SCHEMBL1626497 0.94 KDM4E (0.31)
Methenamine SCHEMBL541058 0.88
Methenamine SCHEMBL2988857 0.88
Methenamine SCHEMBL388812 0.88
Methenamine SCHEMBL8901393 0.88
Methenamine SCHEMBL11529258 0.88
Methenamine SCHEMBL3412566 0.88
Methenamine SCHEMBL6697487 0.88
Methenamine SCHEMBL1261085 0.88
Methenamine SCHEMBL7459586 0.88

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113457720-A HMS @ NiPt @ Beta core-shell structure catalytic material and preparation method and application thereof 东南大学 2021-10-01 CN claimed
CN-112742445-A Selective hydrogenation molecular sieve material and preparation method thereof 中国石油化工股份有限公司 2021-05-04 CN claimed
CN-118320833-A Hydrogenation catalyst composition and preparation method and application thereof 中科(广东)炼化有限公司 2024-07-12 CN disclosed
CN-115572880-B High-entropy metallocenes, preparation method and application thereof 华南理工大学 2023-06-16 CN disclosed
CN-113457720-A HMS @ NiPt @ Beta core-shell structure catalytic material and preparation method and application thereof 东南大学 2021-10-01 CN disclosed
US-20120309952-A1 SMALL RNA PURIFICATION PROMEGA CORPORATION (US) 2012-12-06 US disclosed
EP-1996730-A2 SMALL RNA PURIFICATION PROMEGA CORPORATION (US) 2008-12-03 EP disclosed
US-20070269991-A1 SEMICONDUCTOR NANOCRYSTAL-METAL COMPLEX AND METHOD OF PREPARING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2007-11-22 US disclosed
EP-1857575-A2 Semiconductor nanocrystal-metal complex and method of preparing the same Samsung Electronics Co., Ltd. (KR) 2007-11-21 EP disclosed
US-20070249821-A1 Small RNA purification PROMEGA CORPORATION (US) 2007-10-25 US disclosed
WO-2007103485-A2 SMALL RNA PURIFICATION PROMEGA CORPORATION (US) 2007-09-13 WO disclosed
US-20040102654-A1 Process facilitating the regeneration of a catalyst based on a zeolite used in an acylation reaction, catalyst and use SPAGNOL MICHEL (FR) 2004-05-27 US disclosed
US-20020120169-A1 Process facilitating the regeneration of a catalyst based on a zeolite used in an acylation reaction, catalyst and use SPAGNOL MICHEL (FR) 2002-08-29 US disclosed
CN-1107440-A Process for preparing metal hydroxides STARCK H C GMBH CO KG (DE) 1995-08-30 CN disclosed
US-4628130-A Process for producing alcohols by hydrogenolysis of carboxylic acid esters in the presence of a catalyst containing nickel and tin, germanium or lead INSTITUT FRANCAIS DU PETROLE (FR) 1986-12-09 US disclosed
US-4069164-A COBALT-CONTAINING IRON OXIDE, OXIDIZER FUJI PHOTO FILM CO., LTD. (JA) 1978-01-17 US disclosed